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Our understanding of the mechanisms involved
in mitochondrial biogenesis has continuously
expanded during the last decades, yet little is known
about how they are modulated to optimize the
functioning of mitochondria. Here, we show that
mutations in the ATP binding domain of Bcs1, a
chaperone involved in the assembly of complex III,
can be rescued by mutations that decrease the
ATP hydrolytic activity of the ATP synthase. Our re-
sults reveal a Bcs1-mediated control loop in which
the biogenesis of complex III is modulated by the en-
ergy-transducing activity of mitochondria. Although
ATP is well known as a regulator of a number of
cellular activities, we show here that ATP can be
also used to modulate the biogenesis of an enzyme
by controlling a specific chaperone involved in its
assembly. Our study further highlights the intramito-
chondrial adenine nucleotide pool as a potential
target for the treatment of Bcs1-based disorders.
INTRODUCTION
Mitochondrial oxidative phosphorylation (OXPHOS), which
provides most of the ATP in animal cells, relies upon five multi-
subunit complexes (I–V) embedded within the inner membrane
of mitochondria. The respiratory complexes (I–IV) transfer elec-
trons to the final acceptor, oxygen. This transfer is coupled to
proton translocation across the inner membrane, and the result-
ing transmembrane proton gradient is used by the ATP synthase
(complex V) to synthesize ATP from ADP and inorganic phos-
phate. Due to its dual genetic origin, nuclear and mitochondrial,
the biogenesis of the OXPHOS system is an intricate process
involving numerous factors that execute highly specific functions
ranging from the synthesis of the individual subunits to their
assembly into the respiratory complexes. In addition, the respi-
ratory complexes are organized into supramolecular structures
or ‘‘supercomplexes,’’ also called respirasomes, containingCellcomplexes I, III, and IV in higher eukaryotes and complexes III
and IV in yeast (Scha¨gger and Pfeiffer, 2000; Cruciat et al.,
2000; Heinemeyer et al., 2007; Dudkina et al., 2011).
Complex III has a central position in the respiratory chain,
allowing ubiquinol oxidation and cytochrome c reduction. It is
an important site of proton translocation and production of
reactive oxygen species.Complex III consists of 11or 10different
subunits in mammals and yeast, respectively, three of which are
catalytic: cytochrome b (Cytb), cytochrome c1 (Cyt1) and the
Rieske-FeS protein Rip1 (Iwata et al., 1998; Hunte et al., 2000).
In all eukaryotes, Cytb is encoded by the mitochondrial DNA,
whereas the other complex III subunits have a nuclear origin.
The complex is assembled through a dynamicmodular pathway,
starting with an early core containing Cytb and the subunits
Qcr7 and Qcr8 and finishing with the incorporation of Rip1
(Figure 1A; for reviews, see Zara et al., 2009; Smith et al., 2012).
Two proteins, Mzm1 and Bcs1, are required during the late
stages of complex III assembly in yeast. Mzm1 appears to stabi-
lize Rip1 (Cui et al., 2012). Deficiencies of Bcs1 lead to the accu-
mulation of an inactive pre-complex III (pre-III) lacking Rip1
(Nobrega et al., 1992; Cruciat et al., 1999; 2000; Conte et al.,
2011). Bcs1 mediates the translocation of Rip1 from the matrix
to the intermembrane space, and the release of Rip1 depends
on the hydrolysis of Bcs1-bound ATP (Wagener et al., 2011).
Bcs1 is detected in a high-molecular-weight complex that is
anchored to the inner membrane and protruding into the matrix.
An internal signal within the N-terminal domain targets Bcs1 to
mitochondria (Fo¨lsch et al., 1996). Bcs1 contains a Bcs1-specific
domain and a highly conserved AAA region typical of the AAA-
protein family (ATPase associated with diverse cellular activities;
Figure 1B). This region contains the Walker A and B motifs of
P loop ATPases involved in ATP binding and hydrolysis as well
as a number of additional conserved structural elements such
as the SRH (second region of homology). AAA proteins drive
ATP-dependent dissociation, unfolding, or folding of nucleic
acids and proteins (for review, see Hanson and Whiteheart,
2005). In mitochondria, the AAA proteins play a central role in
the biogenesis and quality control of proteins (Gerdes et al.,
2012).
Mutations in the human gene BCS1L (BCS1-like) are the most
frequent nuclear mutations resulting in complex III-relatedMetabolism 18, 567–577, October 1, 2013 ª2013 Elsevier Inc. 567
Figure 1. The bcs1-F342CMutation Located
in the AAA Domain of Bcs1 Affects the
Assembly of Complex III and of Supercom-
plexes III/IV
(A) Schematic representation of the modular as-
sembly pathway of complex III. The three catalytic
subunits, Cytb, Cyt1, and Rip1, as well as Bcs1 are
in bold.
(B) Schematic representation of the Bcs1 protein.
Positions of the transmembrane domain (TM),
Bcs1-specific domain (gray), and the AAA domain
with the positions of Walker A (red), B (purple),
and SRH (blue) motifs and the amino acid F342
(green, *) are indicated. See also Figure S1.
(C) Theoretical structural model of the AAA domain
of the yeast Bcs1 (amino acids 219–456; Nouet
et al., 2009). The nucleotide (ADP), the main
conserved motifs of AAA proteins, and the residue
F342 are indicated. The figure was generated with
the PyMOL v1.3 software.
(D) Dilution series of cells from WT and bcs1-
F342C were spotted on fermentable (glucose) and
respiratory (glycerol) media and incubated for
4 days at 28C.
(E) Mitochondrial complexes were analyzed by
BN-PAGE and immunoblotted with antibodies
against Cyt1, Cox2, Bcs1, and Atp2. Positions
of the supercomplexes III2 + IV2 and III2 + IV,
the 500 kDa precomplex III (pre-III), dimers of
complex IV (IV2), dimers (V2) and monomers (V)
of ATP synthase, as well as the positions of the
low-amount band (#) and the band sub-V, are
indicated. *, nonspecific band revealed by the
anti-Bcs1 antibody. Positions of the protein
molecular mass markers (669 and 440 kDa) are
indicated. See also Figure S2.
(F) Mitochondrial complexes from WT and
bcs1-F342C were analyzed by a first-dimension
BN-PAGE followed by a second-dimension
SDS-PAGE and then immunoblotted with anti-
bodies against Rip1, Cyt1, Cox2, Atp2, Atp4, and Atp6. Positions of the protein molecular mass markers are indicated.
(G) Mitochondrial proteins purified from WT, bcs1-F342C, Dbcs1, and Drip1 strains were analyzed by SDS-PAGE and immunoblotted with antibodies against
Cytb, Cyt1, Rip1, Cox2, Atp2, and Nam1 as loading control. In our mitochondrial preparations fromWT, the intermediate (i-Rip1) and mature forms of Rip1 were
detected with Rip1 antibodies.
(H) Mitochondrial proteins purified from the QCR7-c-Myc and QCR7-c-Myc bcs1-F342C strains were subjected to coimmunoprecipitation experiments. The
fractions were analyzed by SDS-PAGE and immunoblotted with antibodies against Rip1, Cytb, Cox2, Atp3, and porin as negative control. T, total; S, supernatant;
W, washing; IP, immunoprecipitate.
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with these mutations, ranging from the mild Bjornstad syndrome
to the lethal GRACILE syndrome (e.g., de Lonlay et al., 2001;
Visapa¨a¨ et al., 2002; De Meirleir et al., 2003; Hinson et al.,
2007; Fernandez Vizarra et al., 2007;Mora´n et al., 2010; Kotarsky
et al., 2010; Leve´en et al., 2011). An extensive mutational study
of yeast Bcs1 has revealed the importance of the residues
located at the junction between the Bcs1-specific and the AAA
domains for the activity and stability of the protein (Nouet
et al., 2009). Interestingly, several human pathogenic mutations
are located at this junction.
In this paper, we report the identification of extragenic
compensatorymutations of respiratory-deficient bcs1mutations
located in the ATP binding domain of the yeast protein, among
which one is the equivalent of a mutation found in a human
patient. Remarkably, the compensatory mutations preferentially
target the mitochondrial ATP synthase and lead to a strong568 Cell Metabolism 18, 567–577, October 1, 2013 ª2013 Elsevier Indecrease in the mitochondrial ATP hydrolytic activity while
maintaining a sufficient level of ATP synthesis. We further show
that increasing the ATP concentration in an in vitro assay also
compensates for the Bcs1 deficiency. Based on these findings,
we propose a model in which the ATP dependency of the
protein Bcs1 is not just a requirement for its chaperon activity
but also a way to couple the rate of complex III biogenesis to
the energy-transducing activity of mitochondria.
RESULTS
Characterization of the bcs1-F342C Mutant
Previously, we isolated a yeast mutant with the single amino
acid substitution F342C that modifies a highly conserved region
of the AAA domain of Bcs1 (Nouet et al., 2009; Figure S1 avail-
able online). According to the theoretical three-dimensional
(3D) model of the yeast Bcs1 protein (Figure 1C), the residuec.
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ATP Dependency of Bcs1 and Complex III BiogenesisF342 is located in the vicinity of the conserved SRH motif (see
also Discussion). The bcs1-F342C mutant was unable to grow
on respiratory substrates (Figure 1D), and it did not affect the
steady-state level and oligomerization of Bcs1 (Figure 1E), sug-
gesting that it probably decreased the activity of the protein.
As theOXPHOScomplexes are organized into supramolecular
structures, we have analyzed the effect of the bcs1-F342C
mutation on supercomplexes III/IV and on ATP synthase oligo-
mers. Under the blue native (BN)-PAGE conditions we used,
complexes III and IV were mainly detected in the wild-type
(henceforth designated as WT) as two supercomplexes, III2IV2
and III2IV (Figures 1E and 1F). High-molecular-weight complexes
revealed with the Cyt1 and Cox2 antibodies were detected in the
mutant bcs1-F342C. Two-dimensional BN-SDS analysis (2D)
has shown the absence of Rip1 in these complexes, indicating
that the low amount of Rip1 that accumulates in the bcs1-
F342Cmutant (70% versusWT, Figure 1G) was not incorporated
into complex III. In addition, the typical pre-complex III (pre-III)
previously observed in strains that fail to assemble Rip1 (for re-
view, see Zara et al., 2009; Smith et al., 2012) showed a strong
signal with anti-Cyt1 but a very weak signal with anti-Cox2, as
shown on 2D gels. The weak anti-Cox2 signal in this regionmight
correspond to partial dissociation of higher-molecular-weight
Cox2-containing complexes, yielding some subcomplexes that
comigrate with pre-III. Finally, the complexes around 440 kDa
that are detected with anti-Cox2 in higher abundance in the
mutants probably correspond to free complex IV dimers. Using
a c-Myc-tagged version of the Qcr7 subunit of complex III,
Cox2 was efficiently coimmunoprecipitated in the WT and the
bcs1-F342C mutant, whereas Rip1 was only detected in the
WT immunoprecipitate (Figure 1H). These findings indicate that
pre-III can still interact with complex IV, but the integration of
complex IV into supercomplexes is compromised.
ATP synthase in BN-PAGE was revealed using antibodies
against the subunit Atp2 (Figure 1E). This enzyme was detected
mainly asmonomers (V) and dimers (V2) both inWT andmutants.
The faint band between V and V2 (denoted with a #) also reacted
with antibodies against several other ATP synthase subunits
(Figure S2), suggesting that it could be a dimer that has lost
some subunits during preparation and/or electrophoresis of
the mitochondrial samples. In comparison to V and V2, the
amount of this bandwas too low to be detected in 2D (Figure 1F).
An additional Atp2-containing complex of smaller size (sub-V)
migrating ahead of free F1 was repeatedly observed in the
bcs1-F342C mutant as well as in Dbcs1 and Drip1 strains, but
not in the WT or in other mutants affecting complex III, indicating
that sub-V resulted from a specific lack in Rip1 (Figures 1E and
S2). Due to its low amount, this complex could no longer be
detected in a 2D experiment (Figure 1F). Thus, the bcs1-F342C
mutation only seems to have a slight effect on the integrity of
ATP synthase.
Mutations in the Genes Encoding F1 Subunits
of ATP Synthase Rescue the bcs1-F342C Mutant
As extragenic compensatory mutations may uncover unpredict-
able networks of interacting cellular functions and proteins, we
have applied this approach to the bcs1-F342C mutant in order
to better understand howmitochondria modulate Bcs1 function.
We analyzed four independent revertants of the bcs1-F342CCellmutant (called R2, R3, R12, and R18; Table S1) displaying
various respiratory-sufficient growth phenotypes (Figure 2A).
Each revertant resulted from a compensatory mutation located
in another nuclear gene that we have identified through a com-
bination of molecular cloning and gene candidate approaches
(see Experimental Procedures). DNA sequencing showed that
the bcs1-F342C mutation was still present in each revertant,
and we found missense mutations within the genes ATP1
(atp1-V68G) in R3 and ATP2 (atp2-H400Y, atp2-V499F, and
atp2-A48D) in R2, R12, and R18. The genes ATP1 and ATP2
encode the a and b subunits of the catalytic sector (F1) of the
ATP synthase (Figure 2B). Below, we describe a thorough
biochemical analysis of the properties of the two mutations,
atp1-V68G and atp2-A48D, that exhibited the strongest com-
pensatory effects when associated with the bcs1-F342C muta-
tion in the R3 and R18 revertants.
The level of mature Rip1 and the insertion of functional com-
plex III within supercomplexes was substantially improved in
the bcs1-F342Cmutant by the atp1-V68G and atp2-A48Dmuta-
tions, as revealed by SDS and BN-PAGE analyses (Figure 2C)
and ubiquinol-cytochrome c oxidoreductase activity measure-
ments (Figure 2D). As a result, the oxygen consumption rate in
mitochondria was substantially improved, with values estimated
at 70% in R3 and 30% in R18 with respect to WT, versus
<10% in the bcs1-F342C mutant (Figure 2E and Table S2). The
residual oxygen consumption activity in the bcs1-F342C mutant
did not induce any significant mitochondrial ATP synthesis,
whereas a substantial ATP production of 35% and 15%
with respect to WT was observed in R3 and R18, respectively.
Thus, the atp1-V68G and atp2-A48D mutations improve the
assembly of functional complex III and its insertion into super-
complexes and restore mitochondrial ATP synthesis in the
bcs1-F342C mutant.
The F1 Mutations atp1-V68G and atp2-A48D Lead
to a Strong Decrease in the ATP Synthase Assembly
and Hydrolytic Activity
We next determined how the atp1-V68G and atp2-A48D muta-
tions impact ATP synthase. Being recessive, these mutations
were expected to partially impair the function of the two F1 sub-
units. This possibility was examined first by measurements
of the ATP hydrolytic activity of ATP synthase. Normally, when
properly assembled into F1 oligomers, the Atp1 and Atp2
proteins are responsible for 80%–90% of the ATP hydrolytic
activity of mitochondria. While this activity was mostly unaf-
fected in the bcs1-F342C mutant, it was drastically reduced by
95% in R3 and 80% in R18 with respect to WT (Figure 3A and
Table S3). Similar deficits in ATP hydrolytic activity were
observed in the single mutants atp1-V68G and atp2-A48D. As
revealed by BN-PAGE, both R3 and R18, as well as the single
atp1 and atp2mutants, had a reduced content of fully assembled
F1Fo complexes, and there was no indication of accumulation of
free F1 (Figure 3B). However, despite the reduced content in F1,
the steady levels of the Atp1 and Atp2 were essentially unaf-
fected (Figure 3C). Previous work has shown that these proteins
show a high tendency to form large inclusion bodies in the mito-
chondrial matrix when they cannot associate with each other
(Ackerman and Tzagoloff, 1990; Lefebvre-Legendre et al.,
2005). Aggregates strongly enriched in Atp1 and Atp2 proteinsMetabolism 18, 567–577, October 1, 2013 ª2013 Elsevier Inc. 569
Figure 2. The bcs1-F342C Mutation Is
Compensated for by Mutations in F1 Sub-
units of the Mitochondrial ATP Synthase
R2, bcs1-F342C atp2-H400Y; R3, bcs1-F342C
atp1-V68G; R12, bcs1-F342C atp2-V499F; R18,
bcs1-F342C atp2-A48D.
(A) Dilution series of cells from WT, bcs1-F342C,
and the four revertants, R2, R3, R12, and R18 (see
Table S1) were grown for 3 days at 28C.
(B) The a-F1, b-F1, and g subunits (Atp1 in orange,
Atp2 in green, Atp3 in gray) are represented
according to the structure of the bovine ATP
synthase (Abrahams et al., 1994). The figure was
generated with the VMD 1.9.1. software. The mu-
tations identified in the four revertants are repre-
sented as blue (atp1) and red (atp2) beads. The
inner membrane (IM) is at the top of the figure.
(C) Mitochondrial proteins from WT, bcs1-F342C,
R3, and R18 were analyzed by SDS-PAGE and
BN-PAGE and immunoblotted with antibodies
against Rip1 and Nam1 (SDS) or Cyt1 (BN) (see
Figure 1F legend).
(D) The ubiquinol cytochrome c oxidoreductase
activity (complex III activity) was measured in
purified mitochondria. The activities of the three
mutants are expressed as a percentage of the
wild-type activity (1,800 nmol of reduced cyto-
chrome c/min/mg of proteins). Data represent
the mean of three independent experiments. Data
are represented as mean ± SEM.
(E) The rates of oxygen consumption and ATP
synthesis were measured on fresh, osmotically
protected mitochondria with NADH as a respira-
tory substrate and after the addition of ADP (see
Tables S2 and S3). Both the O2 consumption and
the ATP synthesis are represented as a percent-
age of the wild-type measurements. Data are
represented as mean ± SEM.
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and atp2-A48D cells (Figure S3). Thus, the lowering in mito-
chondrial ATP hydrolytic activity induced by the atp1-V68G
and atp2-A48D mutations is mainly caused by a decreased
ability of the Atp1 and Atp2 proteins to assemble with each
other or by a diminished stability of the F1 oligomers. As a result
of this lower yield in F1, the ATP synthase proton-translocating
domain Fo, whose assembly is dependent on that of F1 (Rak
et al., 2009), also accumulated less efficiently in the atp1-V68G
and atp2-A48D mutants, as shown by their low steady levels in
the Atp6, a main component of the Fo (Figure 3C).
The F1 Mutations atp1-V68G and atp2-A48D Lower
the Energization of the Mitochondrial Inner
Membrane by ATP
The influence of the bcs1-F342C, atp1-V68G and atp2-A48D
mutations was further investigated by mitochondrial membrane
potential (DJ) in vitro analyses. DJ mainly results from the
proton translocation by the respiratory complexes and the ATP
synthase. Consistent with its very low respiratory activity, the
membrane was poorly energized by ethanol in the bcs1-F342C
mutant in comparison to WT, whereas DJ was restored in the
revertants R3 and R18 due to their improved capacity to
assemble complex III. In a first series of experiments (Figure 4A),570 Cell Metabolism 18, 567–577, October 1, 2013 ª2013 Elsevier Inwe tested the effect of the addition of a small amount of ADP,
which induces a DJ consumption while imported into mito-
chondria. Return to the potential established before the addition
of ADP, which reflects its phosphorylation by the ATP synthase,
was null in the bcs1-F342C mutant and much slower in R3 and
R18 than in theWT. In a second series of experiments (Figure 4B),
we directly evaluated the proton pumping activity of the ATP
synthase in the presence of a large excess of ATP. Before the
addition of ATP, the mitochondria were treated with KCN in
order to release, from the F1, the IF1 peptide that inhibits the
ATP hydrolytic activity of F1 (Venard et al., 2003). Consistent
with their high levels of assembled and functional F1Fo com-
plexes, both the WT and bcs1-F342 mutant can efficiently
energize the membrane by hydrolyzing the exogeneous ATP,
whereas R3 and R18 cannot, which is consistent with the ATP
hydrolysis assays, showing the major impact of the atp1 and
atp2 mutations on the ATP hydrolytic activity of F1.
A Specific Mutation in the FO Subunit Atp6 also Rescues
the bcs1-F342C Mutant
In order to better understand the functional links between ATP
synthase and Bcs1, we have tested other mutations in ATP
synthase for their capacity to rescue the bcs1-F342C mutant.
We selected three mutations (atp6-W136R, atp6-L183P, andc.
Figure 3. The atp1-V68G and atp2-A48D Mutations Affect the
Assembly of ATP Synthase and Lead to a Strong Decrease in the
Hydrolytic Activity of F1
Mitochondria were purified from WT, bcs1-F342C, R3 (bcs1-F342C atp1-
V68G), R18 (bcs1-F342C atp2-A48D), atp1-V68G, and atp2-A48D.
(A) Three independent ATP hydrolysis assays were performed on frozen and
thawedmitochondria in the absence of osmotic protection and in the presence
of saturating amounts of ATP. Specific enzyme activities are represented as
a percentage of the wild-type activity (2,135 nM Pi/min/mg of protein). The
percentage of inhibition of ATP hydrolysis by oligomycin is indicated. See
Table S3 for complete data. Data are represented as mean ± SEM.
(B) BN-PAGE was immunoblotted with antibodies against Atp2 and Tom40,
a protein of the mitochondrial outer membrane used as loading control.
(C) SDS-PAGE was immunoblotted with antibodies against Atp1, Atp2, Atp6,
and the loading control Nam1. See also Figure S3.
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ATP Dependency of Bcs1 and Complex III Biogenesisatp6-L247P) affecting Atp6, an essential component of the
Fo proton-translocating domain encoded by the mitochondrial
genome. These mutations correspond to mutations found in
human patients suffering from NARP (neuropathy, ataxia, and
retinitis pigmentosa) or MILS (maternally inherited Leigh syn-Celldrome) (for review, see Houstek et al., 2006). Both the rate of
mitochondrial ATP synthesis and hydrolysis are strongly
reduced by 70% and 90%, respectively, in the apt6-W136R
mutant, while the assembly/stability of the ATP synthase is
normal (Kucharczyk et al., 2012, Figure 5A). The atp6-L183P
and atp6-L247P partially compromise the assembly and/or
stability of Atp6 within the ATP synthase, leading to mitochon-
drial ATP production deficits of 40%–60%, whereas the ATP
hydrolytic activity of mitochondria is only modestly decreased
(Kucharczyk et al., 2009; 2010). Each atp6 mutation was
combined with the bcs1-F342C mutation (see Table S1),
and only the atp6-W136R mutation was able to restore the
growth on glycerol (Figure 5B). In the atp6-W136R bcs1-F342C
double mutant, complex III activity and the insertion of this
complex into supercomplexes were partially recovered, whereas
they were not in the atp6-L183P bcs1-F342C (Figures 5C and
5D). Thus, the F1 mutations (atp1-V68G or atp2-A48D) and the
Fo mutation (atp6-W136R) that all lead to a strong decrease in
the rate of mitochondrial ATP hydrolysis can compensate for
the defect in complex III assembly due to the bcs1-F342C
mutation.
ATP Synthase Mutations Can also Rescue a bcs1
Mutation Found to be Pathogenic in Humans
The results described above might hold promise for developing
therapeutic pathways for human diseases caused by Bcs1 defi-
ciencies. In this respect, since the bcs1-F342C mutation has
no known equivalent in human patients, we wanted to know
whether the ATP synthase-mediated compensation could also
rescue, in yeast, a bcs1 mutation that was known to be patho-
genic in humans. We tested the mutation bcs1-F368I found in
a patient with an early-onset encephalopathy (Fernandez-Vizarra
et al., 2007). We constructed, in yeast, the bcs1-F401I mutation
that is the equivalent of the human bcs1-F368I mutation (Fig-
ure S1). According to theoretical three-dimensional (3D) models
of the human and yeast Bcs1 proteins, this mutation is located
near the ATP binding site of Bcs1 (Figure 5E). The bcs1-F401I
mutation led to a stringent respiratory growth deficiency (Fig-
ure 5F) and very severely compromised the activity of complex
III (Figure 5G). As with the bcs1-F342C mutation, the steady-
state levels and oligomerization of Bcs1 were not affected in
the bcs1-F401I mutant (Figure 5E). Thus, the two mutations
seem to have a very similar impact on Bcs1. Two of the ATP
synthase mutations that rescue the bcs1-F342C mutant, one in
F1 (atp1-V68G) and one in Fo (atp6-W136R), were tested for their
capacity to compensate the bcs1-F401I mutant. The two double
mutants (bcs1-F401I, atp1-V68G and bcs1-F401I, atp6-W136R)
were able to grow on respiratory substrates (Figure 5F) and
showed an improved complex III activity (Figure 5G). These
results suggest that Bcs1 mutations responsible for human
diseases might be treatable by modulation of the ATP synthase
activity.
Increasing the ATP Concentration Compensates for the
In Vitro ATPase Deficiency of the bcs1-F342C Mutant
In order to test if and how the bcs1-F342C mutation affected
the activity of Bcs1, we have set up an in vitro assay allowing
the determination of its ATPase activity. We have purified WT
and mutated Bcs1 proteins carrying a hexahistidine tag fusedMetabolism 18, 567–577, October 1, 2013 ª2013 Elsevier Inc. 571
Figure 4. The atp1-V68G and atp2-A48D
Mutations Lower the Potential of the Mito-
chondrial Inner Membrane by ATP
Membrane potential analyses were performed on
fresh osmotically protected mitochondria from
WT, bcs1-F342C, R3, and R18 using Rh-123,
whose fluorescence decay is proportional to the
mitochondrial membrane potential.
(A and B) A total of 50 mM ADP (A) or 1 mM ATP (B)
was added to follow the energization due to ATP
synthesis or hydrolysis, respectively. The other
additions were 0.5 mg/ml Rh-123, 0.15 mg/ml of
proteins, 10 ml ethanol, 0.2 mM KCN, 6 mg/ml
oligomycin, and 3 mM CCCP. KCN, an inhibitor of
complex IV, was used to collapse the membrane
potential induced by the respiratory chain, oligo-
mycin was used to block the ATP synthase, and
CCCP was used to dissipate the proton gradient
across the inner membrane. Experiments have
been repeated three times.
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ATP Dependency of Bcs1 and Complex III Biogenesisto their C terminus (Figure S4). The tag had no influence on the
chaperone activity of Bcs1, and both proteins kept their capacity
to form oligomers both in vivo and after purification from mito-
chondrial digitonin extracts (Figure 6A). The ATP hydrolytic
activity of the Bcs1 proteins was measured at different con-
centrations of ATP; at 2.5 and 5 mM, the bcs1-F342C protein
had a rate of ATP hydrolysis 2- to 3-fold lower than that of the
WT protein (Figure 6B). However, at higher ATP concentrations
(10 or 20 mM), no significant difference was observed between
the mutant and the WT (Figure 6C). Similar ATPase activities
were obtained in the presence of oligomycin, which rules out
the contamination by complex V during Bcs1 purification.
Thus, it can be inferred that the reduced hydrolytic activity of
bcs1-F342C is probably due to a lower affinity of the mutated
protein for the nucleotide, and increasing its concentration in
the assay compensates this deficiency.
DISCUSSION
Previous work has established that incorporation of the Rip1
protein into the yeast complex III involves a protein, Bcs1,
belonging to the AAA protein family (Nobrega et al., 1992; Cruciat
et al., 1999; 2000; Conte et al., 2011;Wagener et al., 2011). Here,
we report that modulation of the ATP synthase activity can
improve the activity of a mutated Bcs1 protein via its ATP
dependency.
The mutant bcs1-F342C displayed large amounts of pre-III
resulting from a block in Rip1 assembly. The immunoprecipita-
tion (IP) data suggest that pre-III and complex IV can interact in
the absence of Bcs1 and Rip1, as previously proposed with
Rip1 variants (Cui et al., 2012). These interactions are consistent
with current structural models that predict that Rip1 is not
located at the interface between the two complexes (Heine-
meyer et al., 2007). However, according to the BN-PAGE data,572 Cell Metabolism 18, 567–577, October 1, 2013 ª2013 Elsevier Inc.the integration of complex IV into super-
complexes is compromised, suggesting
that Bcs1 and Rip1 are essential to
maintaining the integrity of respiratorychain supercomplexes. Combined defects of OXPHOS com-
plexes were also reported in BCS1L-deficient patients (Fernan-
dez-Vizarra et al., 2007; Mora´n et al., 2010).
Unexpectedly, a main target for compensatory mutations
rescuing the bcs1-F342C mutant was the ATP synthase. Four
spontaneous compensatory mutations were identified as single
amino acid changes in the two subunits, Atp1 and Atp2, that
form the ATP synthase catalytic head. The functional conse-
quences of two of these mutations, V68G in Atp1 and A48D in
Atp2, were characterized. Both changes severely compromise
the capacity of the Atp1 and Atp2 subunits to bind to each other,
leading to their accumulation in the mitochondrial matrix as
large aggregates. As a result, the content in fully assembled
ATP synthase was substantially lowered, leading to a decrease
in the enzyme’s synthetic and hydrolytic activities. Nevertheless,
in the revertant strains (bcs1-F342C + atp1-V68G or atp2-A48D),
the assembly of Rip1 within the complex III was substantially
improved, as compared to the single bcs1-F342C mutant.
To further understand how ATP synthase defects could
improve complex III assembly in the bcs1-F342C mutant, we
tested its compensation by other mutations of this enzyme.
Substantial rescue was observed with the mutation W136R
in the subunit Atp6 of the ATP synthase proton channel. This
mutation had no effect on the assembly of ATP synthase but
seriously impaired its functioning, as shown by strong deficits
in both the ATP hydrolytic and synthetic activities of mitochon-
dria (Kucharczyk et al., 2012). The bcs1-F342C mutant was
not rescued by two other atp6 mutations (L183P and L247P)
that partially compromise incorporation and/or stability of Atp6
within the ATP synthase, and lead to similar decreases in the
rate of ATP synthesis but with only minimal effect on the ATP
hydrolytic activity.
It is difficult to understand how reducing the capacity of the
ATP synthase to produce ATP could rescue Bcs1-mediated
Figure 5. Mutations in Subunits of F1 and FO
Rescue bcs1 Mutations, One of which Is a
Human Disease-Related Mutation Modeled
in Yeast
(A) Comparison of ATP hydrolysis of atp1-V68G,
atp2-V48D, and the three atp6 mutants. Mutants
that compensate for bcs1-F342C are in bold. See
legend of Figure 3A and Table S3.
(B) Dilution series of cells of the WT, bcs1-F342C,
atp6-W136R, atp6-L183P, and the doublemutants
bcs1-F342C and atp6-W136R or atp6-L183P were
grown for 3 days at 28C.
(C) Complex III activity as in legend of Figure 2D.
Data are represented as mean ± SEM.
(D) SDS-PAGE and BN-PAGE analysis of mito-
chondrial proteins as in Figures 1E and 1G.
(E) Theoretical structural model of the AAA domain
of the yeast Bcs1 with the positions of the amino
acids F342, F401, and ADP. Mitochondrial com-
plexes of WT and bcs1-F401I were analyzed
by BN-PAGE and immunoblotted with anti-Bcs1
antibody as in Figure 1E.
(F) Dilution series of cells of WT, bcs1-F401I, and
of the double mutants atp6-W136R bcs1-F401I
and atp1-V68G bcs1-F401I were grown for 4 days
at 28C.
(G) Complex III activity as in legend of Figure 2D.
Data are represented as mean ± SEM.
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ATP Dependency of Bcs1 and Complex III Biogenesisdefects in complex III assembly. It is important to keep in mind
that ATP synthase is a reversible enzyme that can hydrolyse
ATP coupled to the pumping of protons out of the mitochondrial
matrix through the Fo membrane domain (for review, see Acker-
man and Tzagoloff, 2005). In the bcs1-F342C mutant, the elec-
tron flow and proton gradient generation are severely impaired
due to a drastic effect on complex III assembly; the resulting level
of ATP synthesized in this mutant is under the detection
threshold. However, the ATP synthase is normally assembled
and exhibits a wild-type hydrolytic activity that can bemodulated
by the compensatory mutations. Thus, rather than a reduced
capacity of the ATP synthase to produce ATP, it is the low
F1-mediated ATP hydrolysis that is responsible for improving
the assembly of complex III in the bcs1-F342C mutant.
As the steady-state levels and oligomerization of Bcs1 were
not affected by the F342C mutation, it is probable that the
less-efficient capacity to assemble Rip1 is due to an altered
activity of the protein. The mutated residue is within the AAA
domain of Bcs1, close to the SHR motif that is known to be
required for ATP hydrolysis in other AAA proteins (Karata et al.,
1999; Hanson and Whiteheart, 2005). Modeling of the phenylal-
anine-to-cysteine substitution in the theoretical structure of
Bcs1 suggests that the interactions between the position
342 and conserved amino acids of the SRH motif are indeedCell Metabolism 18, 567–577modified (Figure S1). Thus, the activity of
Bcs1 might be compromised by less-effi-
cient ATP hydrolysis. This hypothesis is
supported by the lower ATPase activity
of the mutated, compared to the WT puri-
fied, Bcs1 protein at ATP concentrations
of 2.5–5 mM, but nearly the same activityat higher concentrations. Thus, it can be inferred that the
compensatory activity, conferred by a strong decrease in F1-
mediated ATP hydrolytic activity, results from a higher availability
of ATP within mitochondria increasing the ATPase activity of
the mutated Bcs1 protein and concomitant insertion of Rip1
to give fully assembled complex III. This would allow the reestab-
lishment of a proton gradient and the synthesis of ATP by the
remaining F1-Fo complexes. The resulting ATP synthesis would
further increase the matrix ATP content and stimulate Bcs1
activity. According to this suppressor mechanism, a bcs1muta-
tion not affecting the AAA domain should not be suppressed
by the ATP synthase mutations. This was indeed observed
(data not shown).
The genetic interaction between Bcs1 and ATP synthase
revealed by the present study leads us to propose a model in
which the complex III biogenesis would be modulated by the
energetic state of mitochondria (see Figure 7). When yeast cells
rely on oxidative phosphorylation, the level of ATP inside
mitochondria is high and exchanged against cytosolic ADP to
provide the extramitochondrial compartment of the cell with
energy. Large amounts of complex III are required. In cells
producing ATP by fermentation, the intramitochondrial con-
centration of ATP is low, the glycolytic ATP is imported into
mitochondria by the ADP/ATP translocator, and there is no, October 1, 2013 ª2013 Elsevier Inc. 573
Figure 6. In Vitro ATPase Activity of Purified WT and Mutated Bcs1
(A) Ni-NTA-purified Bcs1 (see Figure S4) was analyzed by 2D BN-PAGE/SDS-
PAGE and immunoblotted with anti-His antibody. Positions of sizemarkers are
indicated.
(B) The in vitro ATPase activity of Ni-NTA partially purified WT and mutated
Bcs1 proteins was measured by monitoring NADH oxidation at 340 nm
through a coupled reaction with pyruvate kinase (PK) and lactate dehydro-
genase (LDH) that kept the ATP concentration constant during the assay.
The absorbance decrease at 340 nm reflects ATPase activity. Control,
no protein added; WT-0 or F342C-0, no ATP added; WT-5 or F342C-5, 5 mM
ATP added.
(C) ATP consumption rates of the mutated versus WT Bcs1 at different
ATP concentrations in the assay (2.5– 20 mM) are represented as
mean values of three independent experiments. Data are represented as
mean ± SEM.
Figure 7. Schema for the Modulation of Complex III Biogenesis
through the ATP-Dependent Activity of Bcs1
(A and B) The ATP/ADP ratio is known to be much higher in respiratory
(ethanol) (A) than in fermentative (glucose) (B) conditions (Beauvoit et al., 1993;
see Discussion).
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that the ATP-dependent activity of Bcs1 is not just a requirement
to exercise its chaperon activity, but also a way to couple the
rate of complex III biogenesis to the energy-transducing activity
of mitochondria.574 Cell Metabolism 18, 567–577, October 1, 2013 ª2013 Elsevier InThe importance of ATP in the control of cellular activities is
well established. There are numerous examples of such control
in catabolic and anabolic pathways, like glycolysis, the Krebs
cycle, and the electron transport chain of mitochondria. How-
ever, in all of these examples, ATP regulates the activity of an
enzyme (e.g., cytochrome oxidase; Beauvoit and Rigoulet,
2001; Ramzan et al., 2010), whereas in the case of Bcs1, ATP
could be used to modulate a late step in the assembly of an
enzyme, complex III. This work shows that ATP might influence
the biogenesis of an enzyme by controlling a protein specifically
involved in its assembly. In the future, it would be interesting
to determine whether other major ATP-dependent systems
involved in mitochondrial quality control, like the m- and i-AAA
proteases, are similarly modulated by the energetic activity of
mitochondria.
The present study further defined the intramitochondrial
adenine nucleotide pool as a potential target to treat Bcs1-based
diseases, since this ATP-dependent compensatory mechanism
is active on another yeast-modeled bcs1 mutation found in
a human patient. We recently showed that yeast models of
ATP synthase disorders could be used for the screening of
drugs active against human diseases caused by defects in this
enzyme (Couplan et al., 2011). Our results indicate that such
an approach might also be fruitful in the case of Bcs1-based
disorders.c.
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Strains and Media
S. cerevisiae strains are listed in Table S1. The nonfermentable media contain
2% glycerol, and the fermentable media contain either 2% glucose or 2%
galactose with 0.1% glucose. Tetrad dissection was performed using a
Singer MSM micromanipulator.
Genetic Identification of the Compensatory Mutations
Respiratory-competent revertants were isolated after plating independent
subclones of the bcs1-F342C mutant on glycerol medium. Genetic crosses
showed that the compensatory mutations were nuclear and extragenic and
allowed the selection of strains carrying only the compensatory mutation
associated to the WT BCS1 gene. Further crosses suggested that the
compensatory mutations of revertants R2, R12, and R18 are located in the
same gene. We have constructed the double mutant carrying the compen-
satory mutations of R3 and R18 associated to the WT BCS1 gene and
shown that it exhibits a complete respiratory deficiency. After transformation
of this double mutant with the wild-type genomic library, two classes of
respiratory-competent transformants carrying ATP1 or ATP2 were isolated.
Sequencing of these two genes revealed that R3 carries a mutation in ATP1,
and R2, R12, and R18 carry mutations in ATP2.
Gene Deletion, Site-Directed Mutagenesis, and Epitope Tagging
The genes were deleted in the WT strain (CW252) by replacing the open
reading frames (ORFs) with the URA3, LEU2, or KanR markers (see Table
S1). The bcs1-F401I mutant was constructed by site-directed mutagenesis
with the Stratagene QuikChange Kit and inserted at the chromosomal
BCS1 locus. Qcr7 as well as the WT and mutant Bcs1 proteins were tagged
at their C termini with c-Myc or hexahistidine epitopes, respectively (Longtine
et al., 1998). We verified that the introduction of the tag did not induce
a respiratory deficiency. All the constructions were verified by PCR amplifi-
cation and sequencing.
Mitochondria Preparation, SDS-PAGE, and BN-PAGE
Cells were grown overnight at 28C in galactose medium, and mitochondria
were isolated according to Lemaire and Dujardin (2008). Mitochondrial
proteins were analyzed on 12% SDS-PAGE. For BN-PAGE, mitochondria
were solubilized in digitonin (2%), and the complexes were separated on
5%–10% polyacrylamide gradient gels (Scha¨gger and Pfeiffer, 2000; Lemaire
and Dujardin, 2008). The BN-PAGE strips were placed on the 12% SDS-PAGE
for the second dimension. Both SDS-PAGE and BN-PAGE were electrotrans-
ferred, and immunodetection was carried out using the chemiluminescent
method from Pierce. Polyclonal antibodies against Cyt1, Bcs1, Cytb, and
Nam1 were raised in the laboratory and used at a 1/30,000 ratio for Cyt1
and 1/5,000 for the others. The polyclonal Anti-Rip1 (1/3,000) is from N. Fisher
(Liverpool, UK); the polyclonal antibodies against the subunits of ATP synthase
(1/10,000) are from J. Velours (Bordeaux, France); the monoclonal anti-Cox2
(1/5,000) is from Molecular Probes; the monoclonal anti-c-Myc (1/20,000) is
from J.M. Galan (Paris, France); the polyclonal anti-SDH (1/500) is from B.
Guiard (Gif sur Yvette, France); and the anti-Tom40 is from C. Meisinger
(Freiburg, Germany).
Coimmunoprecipitation Experiments
Mitochondria were solubilized in 50 mM Tris HCl (pH 7.4), 100 mM NaCl, 1%
digitonine for 30 min at 4C and centrifugated for 15 min at 100,000 3 g.
The supernatants were incubated with polyclonal anti-c-Myc antibodies
coupled with agarose beads. Samples were incubated under gentle shaking
for 90 min at 4C. The beads were washed three times. The fractions were
analyzed by western blotting experiments.
Determination of the Activities of the Respiratory
Complexes III and IV
The activities were measured spectrophotometrically at 550 nm at 25C on
2.5–10 mg of isolatedmitochondria (Lemaire and Dujardin, 2008). The ubiquinol
cytochrome c oxidoreductase (complex III) activity was assayed by the rate
of reduction of cytochrome c in the presence of saturating amounts of decylu-
biquinol, and the cytochrome c oxidase (complex IV) activity was assayed byCellthe rate of cytochrome c oxidation. The inhibitors, antimycin for complex III and
KCN for complex IV, were used to test the specificity of the signal.
Membrane Potential, ATP Synthesis, and Hydrolysis Measurements
Variations of the membrane potential (Dc) were evaluated in respiration buffer
by measurement of rhodamine 123 (Rh-123) fluorescence quenching with a
SAFAS Monaco fluorescence spectrophotometer. Mitochondria were ener-
gized using ethanol as a respiratory substrate instead of NADH because fluo-
rescence of the latter overlaps that of Rh-123. To determine ATP synthesis
rates, mitochondria (0.3 mg) were placed in a 2 ml thermostatically controlled
chamber at 28C in respiration buffer. The reaction was started by the addition
of 4 mM NADH and 1 mM ADP and stopped with 3.5% perchloric acid,
12.5 mM EDTA. Samples were then neutralized to pH 6.5 by addition of 2 M
KOH/0.3 M MOPS. The luciferin/luciferase assay (Thermo Labsystems) was
used to determine ATP concentrations. The specific ATPase activity at pH
8.4 of nonosmotically protected mitochondria (20 mg of proteins) was
measured in the presence of saturating amounts of ATP with or without
oligomycin (Lemaire and Dujardin, 2008).
Purification by Ni-NTA Chromatography of Bcs1 Proteins and
Measurements of In Vitro ATPase Activity
A total of 10 mg of mitochondrial proteins was solubilized in 1 ml of buffer A
(50 mM NaCl, 15% w/v glycerol, 15 mM imidazole, 50 mM sodium phosphate
[pH 7.9]) with 2% digitonin. After 30 min of incubation at 4C, the extract was
clarified by centrifugation at 25,000 3 g for 30 min at 4C. The supernatant
was mixed with 0.25 ml Ni-NTA agarose beads (QIAGEN) and washed with
buffer A. After an overnight incubation at 4C, the flow through was collected
by centrifugation at 1,000 3 g for 1 min at 4C. Beads were washed with
40 volumes of buffer A by centrifugation at 1,000 3 g for 1 min at 4C, and
Bcs1 proteins were eluted with buffer E (50 mM NaCl, 15% w/v glycerol,
250 mM imidazole, 50 mM sodium phosphate [pH 7.9]). The in vitro ATPase
activity was measured at 28C under magnetic stirring in 1 ml of activity buffer
(20 units ml1 of pyruvate kinase, 30 units ml1 of lactate deshydrogenase,
2 mM phosphoenol pyruvate, 0.2 mM NADH, 5 mM MgCl2, 50 mM HEPES
[pH 7.5], and ATP at the concentrations 0, 2.5, 5, 10, or 20 mM). ATP concen-
trations of 0–5 mM were previously used by Augustin et al. (2009). The molar
extinction coefficient of NADH at 340 nm was 6.22 M1 cm1, and the path
length was 1 cm.
SUPPLEMENTAL INFORMATION
Supplemental Information includes four figures and three tables and can be
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